Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) SHZ

12.39

+0(+0.00%)

Updated at June 02 03:05PM

Currency In CNY

Valuation

Market Cap13.04B
Enterprise Value13.02B
P/E Ratio40.29
PEG Ratio-0.64
Price/Sales Ratio4.53
Price/Book Ratio1.75
Enterprise/Revenue4.63
Enterprise/EBITDA25.37

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.14
Operating Margin0.17

Management Effectiveness

Return On Assets0.04
Return On Equity0.04

Income Statement

Revenue2.63B
Revenue/Share2.26
Gross Profit1.09B
EBITDA660.62M
Net Income419.27M
Diluted EPS0.44

Balance Sheet

Total Cash699.24M
Total Cash/Share0.61
Total Debt711.96M
Total Debt/Equity0.09
Current Ratio3.37
Book Value Per Share7.06

Price History

52-Week Change-28.59
52-Week High19.13
52-Week Low10.48
Moving Average 50 Days12.34
Moving Average 200 Days14.44

Statistics

Average Volume10.6M
Shares Outstanding950.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.38
Trailing Annual Dividend Yield3.1
Payout Ratio0.76
Last Split Factor1952679:1000000
Last Split DateJuly 27, 2020